These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2677298)

  • 21. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
    Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
    Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
    Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
    Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines.
    Levitz SM; Farrell TP
    Infect Immun; 1990 May; 58(5):1201-9. PubMed ID: 2182538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opsonization and phagocytosis of Cryptococcus neoformans.
    Kozel TR
    Arch Med Res; 1993; 24(3):211-8. PubMed ID: 8298269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route--Part II: Phagocytosis and intracellular fate of Cryptococcus neoformans.
    Karaoui RM; Hall NK; Larsh HW
    Mykosen; 1977 Nov; 20(11):409-12. PubMed ID: 339078
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection.
    Vecchiarelli A; Dottorini M; Pietrella D; Monari C; Retini C; Todisco T; Bistoni F
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):130-7. PubMed ID: 8049074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.
    Cross CE; Collins HL; Bancroft GJ
    Immunology; 1997 Jun; 91(2):289-96. PubMed ID: 9227330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggregates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages.
    Lundborg M; Dahlén SE; Johard U; Gerde P; Jarstrand C; Camner P; Låstbom L
    Environ Res; 2006 Feb; 100(2):197-204. PubMed ID: 16171796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.
    García-Rodas R; Zaragoza O
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):147-61. PubMed ID: 22029633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.
    Mitchell TG; Friedman L
    Infect Immun; 1972 Apr; 5(4):491-8. PubMed ID: 4564677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural cellular resistance of beige mice against Cryptococcus neoformans.
    Hidore MR; Murphy JW
    J Immunol; 1986 Dec; 137(11):3624-31. PubMed ID: 3537121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.
    Zaragoza O; Taborda CP; Casadevall A
    Eur J Immunol; 2003 Jul; 33(7):1957-67. PubMed ID: 12884862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
    Kozel TR; Follette JL
    Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential binding of acapsulate and encapsulated strains of Cryptococcus neoformans to human neutrophils.
    Richardson MD; White LJ; McKay IC; Shankland GS
    J Med Vet Mycol; 1993; 31(3):189-99. PubMed ID: 8360810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.
    Small JM; Mitchell TG
    Infect Immun; 1989 Dec; 57(12):3751-6. PubMed ID: 2680980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The defensive role of human pulmonary alveolar macrophages and polymorphonuclear leukocytes against a strongly or weakly virulent strains of Cryptococcus neoformans].
    Tabeta H; Kohno N; Kamei K; Honda A; Unno H; Nagao K; Yamaguchi T; Miyaji M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1174-9. PubMed ID: 1753544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage-mediated fungistasis: requirement for a macromolecular component in serum.
    Granger DL; Perfect JR; Durack DT
    J Immunol; 1986 Jul; 137(2):693-701. PubMed ID: 3522734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
    Kozel TR
    Infect Immun; 1983 Mar; 39(3):1214-9. PubMed ID: 6341232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.
    Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
    Infect Immun; 1988 Nov; 56(11):2794-800. PubMed ID: 3049374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, phagocytosis, and L-arginine.
    Brummer E; Stevens DA
    Cell Immunol; 1994 Aug; 157(1):1-10. PubMed ID: 8039240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.